|
Volumn 69, Issue 12, 2014, Pages 1149-1151
|
Essential medicines for COPD and asthma in low and middle-income countries
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
AMINOPHYLLINE;
BECLOMETASONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
SALBUTAMOL;
THEOPHYLLINE;
ANTIASTHMATIC AGENT;
RESPIRATORY TRACT AGENT;
ARTICLE;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DISEASE EXACERBATION;
DRUG DOSAGE FORM;
DRUG MARKETING;
HEALTH CARE ACCESS;
LOWEST INCOME GROUP;
MIDDLE INCOME COUNTRY;
PRACTICE GUIDELINE;
SOCIAL STATUS;
DEVELOPING COUNTRY;
HEALTH CARE DELIVERY;
HUMAN;
INCOME;
PUBLICATION;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
STATISTICS AND NUMERICAL DATA;
SUPPLY AND DISTRIBUTION;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
DEVELOPING COUNTRIES;
FORMULARIES AS TOPIC;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INCOME;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RESPIRATORY SYSTEM AGENTS;
|
EID: 84919768669
PISSN: 00406376
EISSN: 14683296
Source Type: Journal
DOI: 10.1136/thoraxjnl-2014-205249 Document Type: Article |
Times cited : (34)
|
References (5)
|